Status: Not yet recruiting
Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer
Phase III, single-center, randomized, double-blind, placebo-controlled, 2x2 cross- over study, assessing the efficacy of CBD in patients with early HR+ BC, presenting aromatase inhibitor-related musculoskeletal pain
Participants needed: 130
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: Gustave Roussy, Cancer Campus, Grand ParisUpdated: Dec 2, 2025Locations: 1
Eligibility criteria
Patient must understand, sign and date the written informed consent form (ICF) p... [+30]
Patient with distant metastases of breast cancer beyond regional lymph nodes (M1... [+25]